Evil forces and vulnerable brains
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
A common theme in all of Shakespeare’s tragedies is the struggle with internal and external forces of evil. Determining the source of evil, internal or external, can be a difficult task for the reader. In Julius Caesar, Brutus is seen as the conflicted evil friend who kills Caesar to save Rome, but only because he saw Caesar as a potential threat to freedom. King Lear’s children are often seen as evil, but it is Lear’s pride that leads him to give away his kingdom too early. Coriolanus’ greatness as a warrior is not only the source of his heroic grandeur, but also of a self-destructive evil. He dies embracing his narcissism to the very end, with the help of a very self-righteous and evil mother.
In this issue of Neurology, the provocative article by Whalley et al.1 forces us to consider whether AD is a developmental process beginning at conception or whether it is a disease acquired en route to old age. To draw a parallel with Shakespeare, is the evil internal (developmental) or external (acquired)? A cohort of individuals born in Scotland in 1921 underwent intelligence tests at age 11 years in 1932, while attending school. The authors then …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Victoria Leavitt and Dr. Laura Hancock
► Watch
Related Articles
Alert Me
Recommended articles
-
Brief Communications
An African American family with early-onset Alzheimer disease and an APP (T714I) mutationT. Edwards-Lee, J. M. Ringman, J. Chung et al.Neurology, January 24, 2005 -
Articles
Amyloidogenic processing of β-amyloid precursor protein in intracellular compartmentsKulandaivelu S. Vetrivel, Gopal Thinakaran et al.Neurology, December 16, 2005 -
Views & Reviews
The molecular and genetic basis of AD: The end of the beginningThe 2000 Wartenberg lectureRoger N. Rosenberg et al.Neurology, June 13, 2000 -
Articles
Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathyA. M. Remes, S. Finnilä, H. Mononen et al.Neurology, July 26, 2004